Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT03896945
PHASE2/PHASE3

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

View on ClinicalTrials.gov

Summary

This study was conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.

Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Negative Symptoms of Schizophrenia

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

136

Start Date

2019-02-15

Completion Date

2023-05-23

Last Updated

2026-09-29

Healthy Volunteers

No

Conditions

Interventions

DRUG

Placebo

oral capsules

DRUG

AVP-786

oral capsules

Locations (72)

Clinical Research Site

Little Rock, Arkansas, United States

Clinical Research Site #840-041

Anaheim, California, United States

Clinical Research Site #840-013

Bellflower, California, United States

Clinical Research Site #840-079

Costa Mesa, California, United States

Clinical Research Site #840-027

Culver City, California, United States

Clinical Research Site #840-006

Garden Grove, California, United States

Clinical Research Site #840-026

Glendale, California, United States

Clinical Research Site# 840-067

La Habra, California, United States

Clinical Research Site# 840-083

Lafayette, California, United States

Clinical Research Site 840-002

Lemon Grove, California, United States

Clinical Research Site

Oakland, California, United States

Clinical Research Site #840-035

Oceanside, California, United States

Clinical Research Site# 840-010

Panorama City, California, United States

Clinical Research Site #840-012

Riverside, California, United States

Clinical Research Site# 840-081

San Bernardino, California, United States

Clinical Research Site #840-005

San Diego, California, United States

Clinical Research Site #840-096

Santee, California, United States

Clinical Research Site #840-015

Torrance, California, United States

Clinical Research Site# 840-094

Doral, Florida, United States

Clinical Research Site #840-046

Hollywood, Florida, United States

Clinical Research Site Site #840-093

Homestead, Florida, United States

Clinical Research Site #840-062

Lakeland, Florida, United States

Clinical Research Site #840-024

Largo, Florida, United States

Clinical Research Site #840-032

Miami, Florida, United States

Clinical Research Site #840-080

Miami, Florida, United States

Clinical Research Site #840-084

Miami Lakes, Florida, United States

Clinical Research Site

Okeechobee, Florida, United States

Clinical Research Site # 840-102

Weston, Florida, United States

Clinical Research Site #840-088

Atlanta, Georgia, United States

Clinical Research Site #840-091

Atlanta, Georgia, United States

Clinical Research Site #840-008

Atlanta, Georgia, United States

Clinical Research Site #840-063

Decatur, Georgia, United States

Clinical Research Site

Chicago, Illinois, United States

Clinical Research Site #840-090

Springfield, Illinois, United States

Clinical Research Site

Lake Charles, Louisiana, United States

Clinical Research Site #840-098

Shreveport, Louisiana, United States

Clinical Research Site #840-072

Worcester, Massachusetts, United States

Clinical Research Site #840-057

Flowood, Mississippi, United States

Clinical Research Site #840-040

Olivette, Missouri, United States

Clinical Research Site #840-029

Saint Charles, Missouri, United States

Clinical Research Site #840-034

Saint Charles, Missouri, United States

Clinical Research Site

St Louis, Missouri, United States

Clinical Research Site #840-025

St Louis, Missouri, United States

Clinical Research Site #840-028

Berlin, New Jersey, United States

Clinical Research Site #840-009

Jamaica, New York, United States

Clinical Research Site #840-070

New York, New York, United States

Clinical Research Site

Rochester, New York, United States

Clinical Research Site #840-074

Charlotte, North Carolina, United States

Clinical Research Site #840-052

Middleburg Heights, Ohio, United States

Clinical Research Site

Edmond, Oklahoma, United States

Clinical Research Site #840-065

Oklahoma City, Oklahoma, United States

Clinical Research Site #840-061

Media, Pennsylvania, United States

Clinical Research Site

Norristown, Pennsylvania, United States

Clinical Research Site #840-099

Myrtle Beach, South Carolina, United States

Clinical Research Site

Memphis, Tennessee, United States

Clinical Research Site

DeSoto, Texas, United States

Clinical Research Site #840-058

Fort Worth, Texas, United States

Clinical Research Site #840-018

Richardson, Texas, United States

Clinical Research Site

San Antonio, Texas, United States

Clinical Research Site #840-069

Springville, Utah, United States

Clinical Research Site #840-051

Everett, Washington, United States

Clinical Research Site #009

Kazanlak, Bulgaria

Clinical Research Site #100-008

Novi Iskar, Bulgaria

Clinical Research Site #100-007

Plovdiv, Bulgaria

Clinical Research Site #100-004 2

Sofia, Bulgaria

Clinical Research Site #100-006

Veliko Tarnovo, Bulgaria

Clinical Research Site #100-001

Vratsa, Bulgaria

Clinical Research Site

Tuszyn, Woj.Iodzkie, Poland

Clinical Research Site #616-002

Bełchatów, Poland

Clinical Research Site #616-003

Pruszcz Gdański, Poland

Clinical Research Site #630-001

San Juan, Puerto Rico

Clinical Research Site # 630-002

San Juan, Puerto Rico